Hospital-acquired pneumonia risk factors for antimicrobial-resistant causative pathogens in critically III patients

Chest

Volumn 123, Issue 6, 2003, Pages 2034-2042

  Leroy, Olivier ^a,b   Jaffré, Sandrine ^a   D'Escrivan, Thibaud ^a   Devos, Patrick ^a   Georges, Hugues ^a   Alfandari, Serge ^a   Beaucaire, Gilles ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b Hopital Chatilliez   (France)

Author keywords

Antimicrobial resistance; Antimicrobial therapy; Hospital acquired pneumonia; ICU; Pneumonia

Indexed keywords

ANTIBIOTIC AGENT;

ALGORITHM; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; ASPIRATION; BACTERIAL PNEUMONIA; BACTERIUM ISOLATION; BLOOD PRESSURE MONITORING; CHRONIC RESPIRATORY FAILURE; COHORT ANALYSIS; CONTROLLED STUDY; CRITICAL ILLNESS; ENDOTRACHEAL INTUBATION; HIGH RISK PATIENT; HOSPITAL INFECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; NASOGASTRIC TUBE; NEUROLOGIC DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; THORAX RADIOGRAPHY; TRACHEOSTOMY; VALIDATION PROCESS;

EID: 0037709767     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.123.6.2034     Document Type: Article

References (34)

1. Fagon JY, Chastre J, Hance AJ, et al. Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med 1993; 94:281-288
2. Kollef MH, Silver P, Murphy DM, et al. The effect of late-onset ventilator-associated pneumonia in determining patient mortality. Chest 1995; 108:1655-1662
3. Papazian L, Bregeon F, Thirion X, et al. Effect of ventilator-associated pneumonia on mortality and mortality. Am J Respir Crit Care Med 1996; 154:91-97
4. Fagon JY, Chastre J, Vuagnat A, et al. Nosocomial pneumonia and mortality among patients in intensive care units. JAMA 1996; 275:866-869
5. Heyland DK, Cook DJ, Griffith L, et al. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient: The Canadian Critical Trials Group. Am J Respir Crit Care Med 1999; 159:1249-1256
6. Leroy O, Guilley J, Georges H, et al. Effect of hospital-acquired ventilator-associated pneumonia on mortality of severe community-acquired pneumonia. J Crit Care 1999; 14:12-19
7. Bercault N, Boulain T. Mortality rate attributable to ventilator-associated nosocomial pneumonia in an adult intensive care unit: a prospective case-control study. Crit Care Med 2001; 29:2303-2309
8. Leroy O, Sanders V, Girardie P, et al. Mortality due to ventilator-associated pneumonia: impact of medical vs surgical ICU admittance status. J Crit Care 2001; 16:90-97
9. American Thoracic Society. Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventative strategies. Am J Respir Crit Care Med 1995; 153:1711-1725
10. Kollef MH, Ward S. The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator-associated pneumonia. Chest 1998; 113:412-420
11. Luna CM, Vujacich P, Niederman MS, et al. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest 1997; 111:676-685
12. Kollef MH, Fraser VJB. Antibiotic resistance in the intensive care unit. Ann Intern Med 2001; 134:298-314
13. Kollef MH. Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. Clin Infect Dis 2000; 31(suppl 4):S131-S138
14. McCabe WR, Jackson CG. Gram-negative bacteremia: etiology and ecology. Arch Intern Med 1962; 110:847-855
15. Le Gall JR, Lemeshow S, Saulnier F. Simplified Acute Physiologic Score: a new simplified acute physiologic score (SAPSII) based on European/North American multicenter study. JAMA 1993; 27:2957-2963
16. Knaus WA, Graper EA, Wagner DP, et al. Prognosis in acute organ system failure. Ann Surg 1985; 202:685-693
17. Teasdale G, Jennet B. Assessment of coma and impaired consciousness: a practical scale. Lancet 1974; 2:81-84
18. Finegold SM. Aspiration pneumonia. Rev Infect Dis 1991; 13(suppl 9):S737-S742
19. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987; 136:225-244
20. Bone RC, Fischer CJ, Clemmer TP, et al. Sepsis syndrome: a valid clinical entity; The Methylprednisolone Severe Sepsis Study Group. Crit Care Med 1989; 17:389-393
21. Antibiogram Committee of the French Society for Microbiology: official statement 1999. Pathol Biol (Paris) 1999; 47:845-872
22. Hartigan JA. Clustering algorithms. New York, NY: John Wiley & Sons, 1975
23. Trouillet JL, Chastre J, Vuagnat A, et al. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Ann J Respir Crit Care Med 1998; 157:513-539
24. Rello J, Ausina V, Ricart M, et al. Impact of previous antimicrobial therapy on the etiology and outcome of ventilator-associated pneumonia. Chest 1993; 104:1230-1235
25. Rello J, Ausina V, Ricart M, et al. Risk factors for infection by Pseudomonas aeruginosa in patients with ventilator-associated pneumonia. Intensive Care Med 1994; 90:193-198
26. Rello J, Torres A, Ricart M, et al. Ventilator-associated pneumonia by Staphylococcus aureus. Am J Respir Crit Care Med 1994; 150:1545-1549
27. Baraibar J, Correa H, Mariscal D, et al. Risk factors for infection by Acinetobacter baumannii in intubated patients with nosocomial pneumonia. Chest 1997; 112:1050-1054
28. Rello J, Quintana E, Ausina V, et al. Risk factors for Staphylococcus aureus nosocomial pneumonia in critically ill patients. Am Rev Respir Dis 1990; 142:1320-1324
29. European Task Force on Ventilator-Associated Pneumonia. Ventilator-associated pneumonia. Eur Respir J 2001; 17:1034-1045
30. Kollef MH. Hospital-acquired pneumonia and de-escalation of antimicrobial treatment. Crit Care Med 2001; 29:1473-1474
31. Mayhall CG. Prevention and control of vancomycin resistance in Gram-positive coccal microorganisms: fire prevention and fire fighting. Infect Control Hosp Epidemiol 1996; 17:353-355
32. Smith TL, Pearson ML, Wilcox KR, et al. Emergence of vancomycin resistance in Staphylococcus aureus. N Engl J Med 1999; 340:493-501
33. Grossman RF, Fein A. Evidence-based assessment of diagnostic tests for ventilator-associated pneumonia. Chest 2000; 117:177S-181S
34. Rello J, Sa-Borges M, Correa H, et al. Variations in etiology of ventilator-associated pneumonia across four treatment sites: implications for antimicrobial prescribing practices. Am J Respir Crit Care Med 1999; 160:608-613